Fredrik Berg
Keine laufenden Positionen mehr
Profil
Fredrik Berg formerly worked at Procordia AB, as Legal Counsel, Pharmacia AB, as Head-Legal & Intellectual Property from 1997 to 2001, Biovitrum AB, as SVP-Legal & Intellectual Property in 2010, Kabi Pharmacia, as Legal Counsel, Kabivitrum AB, as Legal Counsel, and Swedish Orphan Biovitrum AB, as Vice President & General Counsel.
Mr. Berg received his graduate degree from the University of Stockholm.
Ehemalige bekannte Positionen von Fredrik Berg
| Unternehmen | Position | Ende |
|---|---|---|
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | General Counsel | 13.05.2010 |
| Pharmacia AB | General Counsel | 01.01.2001 |
| Kabi Pharmacia | General Counsel | - |
| Procordia AB | General Counsel | - |
| Kabivitrum AB | General Counsel | - |
Ausbildung von Fredrik Berg
| University of Stockholm | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Procordia AB | Health Technology |
| Pharmacia AB | Health Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Kabi Pharmacia | |
| Kabivitrum AB |
